These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
828 related articles for article (PubMed ID: 31472955)
21. Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. Chyau CC; Wang HF; Zhang WJ; Chen CC; Huang SH; Chang CC; Peng RY Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935815 [TBL] [Abstract][Full Text] [Related]
22. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha. Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197 [TBL] [Abstract][Full Text] [Related]
23. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
24. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease. Fu D; Cui H; Zhang Y Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812 [TBL] [Abstract][Full Text] [Related]
25. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα. Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215 [TBL] [Abstract][Full Text] [Related]
26. Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes. Veeramani C; Alsaif MA; Al-Numair KS Biomed Pharmacother; 2017 Dec; 96():1349-1357. PubMed ID: 29174039 [TBL] [Abstract][Full Text] [Related]
27. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways. You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984 [TBL] [Abstract][Full Text] [Related]
28. Shin MR; Shin SH; Roh SS Can J Gastroenterol Hepatol; 2020; 2020():8812634. PubMed ID: 33425805 [TBL] [Abstract][Full Text] [Related]
29. Antrodia cinnamomea Prevents Obesity, Dyslipidemia, and the Derived Fatty Liver via Regulating AMPK and SREBP Signaling. Peng CH; Yang MY; Yang YS; Yu CC; Wang CJ Am J Chin Med; 2017; 45(1):67-83. PubMed ID: 28161992 [TBL] [Abstract][Full Text] [Related]
30. Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase. Yang M; Li X; Zeng X; Ou Z; Xue M; Gao D; Liu S; Li X; Yang S Am J Chin Med; 2016; 44(3):551-64. PubMed ID: 27109162 [TBL] [Abstract][Full Text] [Related]
31. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway. Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596 [TBL] [Abstract][Full Text] [Related]
32. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase. Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089 [TBL] [Abstract][Full Text] [Related]
33. Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995 [No Abstract] [Full Text] [Related]
34. Nguyen HT; Gu M; Werlinger P; Cho JH; Cheng J; Suh JW Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362221 [TBL] [Abstract][Full Text] [Related]
35. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease. Xiao Z; Chu Y; Qin W Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242 [TBL] [Abstract][Full Text] [Related]
36. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092 [TBL] [Abstract][Full Text] [Related]
37. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway. Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489 [TBL] [Abstract][Full Text] [Related]
38. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
39. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944 [TBL] [Abstract][Full Text] [Related]
40. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats. Zou B; Ge ZZ; Zhang Y; Du J; Xu Z; Li CM Food Funct; 2014 Jul; 5(7):1536-46. PubMed ID: 24841999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]